Nomura Holdings, Inc.
NYSE:NMRFinancial - Capital Markets
-$0.12 today
- Market cap
- $27.29B
- Beta
- 0.61
- P/E (TTM)
- 0.3
- EPS (TTM)
- $4,986.67
- Dividend yield
- 3.55%
Volume 3.51M
Average 1.75M
NMR Total Liabilities
Everything the company owes to creditors and other parties.
Nomura Holdings, Inc.NYSE: NMR
Total Liabilities · Q1 FY2027 · quarter ended Jun 2026
Total liabilities rises 17.8% from a year ago
Total liabilities stood at ¥64.23T at the end of Q1 FY2027, up 17.8% from a year earlier and up 9.3% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Total liabilities amounted to 94.1% of total assets at the end of Q1 FY2027, up 0.3 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +17.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
JPY · from the balance sheet
- Latest · FY2026
- 58.79T JPY
- Year-over-year change
- +10.5%
- 4-year CAGR
- +9.8%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 58.79T | +10.5% |
| FY2025 | 2025-03-31 | 53.22T | +2.9% |
| FY2024 | 2024-03-31 | 51.7T | +16.1% |
| FY2023 | 2023-03-31 | 44.55T | +10.2% |
| FY2022 | 2022-03-31 | 40.44T | — |
Total Liabilities vs competitors
How NMR compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +17.8% is the 4th highest of 9, against a peer median of +10.5%.
- Total liabilities amounts to 94.1% of total assets for NMR, versus a peer median of 81.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | ¥64.23T JPY | +17.8% | +9.7% | 94.1% | |
| Sep 2026 | $2.06T USD | +22.8% | +8.3% | 94.3% | |
| Jun 2026 | $1.62T USD | +2.4% | +13.4% | 94.8% | |
| Aug 2026 | $70.55B USD | +19.9% | +17.1% | 86.8% | |
| Jun 2026 | $38.9B USD | +13.5% | +3.8% | 86.6% | |
| Sep 2026 | $3.5B USD | -4.9% | -4.9% | 76.9% | |
| Mar 2026 | $2.9B USD | +7.5% | +12.9% | 75.0% | |
| Jun 2026 | $2.52B USD | +42.4% | +17.1% | 53.7% | |
| Sep 2026 | -$117.44B USD | -109.4% | +6.6% | 6.9% | |
| Peer median (excluding NMR) | — | +10.5% | +10.6% | 81.8% | |
Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.06T | 4.52T | 5.15T | 5.51T | 4.3T |
| Short-term Investments | 10.59T | 0 | 0 | 0 | 709.64B |
| Net Receivables | 5.41T | 1.5T | 1.68T | 1.64T | 1.8T |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 426.52B | 0 | 0 | 0 | 52.28T |
| Total Current Assets | 20.51T | 6.04T | 6.86T | 7.18T | 59.08T |
| Property, Plant & Equipment (Net) | 419.05B | 464.32B | 448.79B | 436.45B | 543.85B |
| Goodwill | 14.41B | 17.64B | 19.26B | 17.2B | 0 |
| Intangible Assets | 15.6B | 18.56B | 19.13B | 56.15B | 0 |
| Long-term Investments | 4.79T | 5.19T | 6.78T | 7.56T | 1.42T |
| Tax Assets | 15.56B | 22.65B | 24.25B | 25.22B | 0 |
| Other Non-current Assets | 17.65T | 36.02T | 41T | 41.52T | 1.6T |
| Total Non-current Assets | 22.9T | 41.73T | 48.29T | 49.62T | 3.56T |
| Total Assets | 43.41T | 47.77T | 55.15T | 56.8T | 62.65T |
| Account Payables | 1.52T | 1.36T | 1.31T | 1.38T | 1.6T |
| Short-term Debt | 13.62T | 15.23T | 17.93T | 17.41T | 1.75T |
| Tax Payables | 34.16B | 42.25B | 81.59B | 88.42B | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.41T | 12.7T | 13.25T | 14.48T | 34.65T |
| Total Current Liabilities | 28.69T | 29.76T | 33.08T | 33.82T | 41.43T |
| Long-term Debt | 9.65T | 10.73T | 12.85T | 13.77T | 15.54T |
| Deferred Tax Liabilities | 0 | 93.83B | 85.3B | 113.82B | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.9T | 3.76T | 5.5T | 5.35T | 1.81T |
| Total Non-current Liabilities | 11.75T | 14.79T | 18.62T | 19.4T | 17.36T |
| Total Liabilities | 40.44T | 44.55T | 51.7T | 53.22T | 58.79T |
| Common Stock | 594.49B | 594.49B | 594.49B | 594.49B | 594.49B |
| Retained Earnings | 1.61T | 1.65T | 1.71T | 1.87T | 2.01T |
| Accumulated OCI | 127.97B | 318.45B | 459.98B | 447.81B | 548.22B |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 58.2B | 75.58B | 98.32B | 110.12B | 147.05B |
| Total Equity | 2.97T | 3.22T | 3.45T | 3.58T | 3.85T |
| Total Debt | 23.48T | 26.15T | 30.96T | 31.35T | 17.3T |
| Net Debt | 19.41T | 21.63T | 25.81T | 25.83T | 13T |
Nomura Holdings, Inc.
NYSE:NMR
Intrinsic Alpha fair value
Locked
Current Price
$9.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.